Abstract
Oral hormonal contraceptives have been available since the early 1960s when Pincus and Rock found that norethynodrel (9.65 mg) in combination with mestranol (150 μg) inhibited ovulation and provided sufficient control of the menstrual cycle. Since then, different approaches to contraception have been pursued. Hormonal steroids can either act as ovulation inhibitors or prevent conception by altering the cervical mucus.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
De Ligniers B, Basdevant A, Thomas G et al. (1986) Biological effect of estradiol 17β in postmenopausal women: oral versus percutaneous administration. J Clin Endocrinol Metab 62:536
Elkik F, Basdevant A, Jackanicz TM, Guy-Brand B, Mercier-Bodard C, Conard J, Bardin CW, Corvol P (1986) Contraception in hypertensive women using a vaginal ring delivering estradiol and levonorgestrel. J Clin Endocrinol Metab 63:29
Hahn DW, McGuire JL, Cohn RM, Beck LR, Tice TR, Lewis DH (1984) Development of microencapsulated norgestimate as a long-acting contraceptive. In: Zatuchni GI, Mishell DR, Shoupe D, Goldsmith A, Shelton JD, Sciarra J J (eds) Long-acting contraceptive delivery systems. Harper and Row, Philadelphia, pp 96–112
Holst J, Cajander S, Carlstrom K, Damber MG, von Schoulz B (1983) Percutaneous oestrogen therapy opposed by lunestrenol or natural progesterone—effects on circulating oestrogens, FSH, sex hormone binding globulin and pregnancy zone protein. Maturitas 5:1–8
Juzpe AA (1984) Postcoital contraception. Clin Obstet and Gynaecol 11:787–797
Laufer LR, De Fazzio JL, Lu JKH et al. (1983) Estrogen replacement therapy by transdermal estradiol administration. Am J Obstet Gynecol 146:533
Rifkind BM, Segal P (1983) Lipid research clinics programm reference values for hyperlipidemia and hypolipidemia. J Am Med Ass 250:1869–1872
Lobo RA, March CM, Goebelsmann U et al. (1980) Subdermal estradiol pellets following hysterectomy and oophorectomy. Am J Obstet Gynecol 138:714
Population Reports (1987) Injectables and implants. Popul Rep 3
Shoupe D, Spitz I, Osborn C, Page MA, Mishell DR Jr, Lobo RA (1986) Effects of progesterone (P) antagonists on gonadotropins at midcycle and during the luteal phase. In: Society for gynecologic investigation, Toronto, Ontario, Canada, 19–22 March 1986, abstract 40
Skouby SO (1987) Oral contraceptives and diabetes mellitus. Gynecol Endocrinol (Suppl) 2:30
Stumpf PG, Maruca J, Santen RJ et al. (1982) Development of a vaginal ring for achieving physiologic levels of 17β estradiol in hypoestrogenic women. J Clin Endocrinol Metab 54:298
Van Santen MR (1987) Postcoital interception and contragestion. Elinkwijk, Utrecht
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Runnebaum, B., Rabe, T., Kiesel, L. (1988). Trends in Hormonal Contraception. In: Runnebaum, B., Rabe, T., Kiesel, L. (eds) Female Contraception. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73790-9_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-73790-9_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-73792-3
Online ISBN: 978-3-642-73790-9
eBook Packages: Springer Book Archive